The application of biological treatments based on blood components, like plasma rich in platelets (PRP), in fields like odontology, is growing due to their regenerative power.< Oral implantology
Endoret® (PRGF®) is a platelet-rich plasma (PRP) technology for obtaining autologous proteins from the patient's own blood.
A system through which we obtain plasma rich in growth factors which is 100% autologous, ensuring its biosafety and avoiding any risk of rejection on the part of the patient.
Patient safety: given that it is an autologous product, the plasma obtained has no adverse effects or risk of incompatibility, offering high patient safety.
Use of the Endoret system, developed by BTI, is vital for elaborating plasma with a suitable biochemical composition.
All of the components are guaranteed by the ISO 13485:2016 and MDSAP certifications, CE certification in accordance with the European Directive on medical devices 93/42/ CEE, granted by TÜV-SÜD Product Service GmbH.